Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03866382 |
Title | Cabozantinib in Combination With Nivolumab and Ipilimumab in Rare Genitourinary Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications |
papillary renal cell carcinoma sarcomatoid transitional cell carcinoma urinary bladder small cell neuroendocrine carcinoma bladder squamous cell carcinoma |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |